Kaletra and Lipodystrophy acquired - a phase IV clinical study of FDA data
Summary:
Lipodystrophy acquired is reported as a side effect among people who take Kaletra (lopinavir; ritonavir), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Viread, and have Depression.
The phase IV clinical study analyzes which people have Lipodystrophy acquired when taking Kaletra. It is created by eHealthMe based on reports of 22,879 people who have side effects when taking Kaletra from the FDA, and is updated regularly.
What is Kaletra?
Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.
What is Lipodystrophy acquired?
Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired) is found to be associated with 174 drugs and 238 conditions by eHealthMe. Check the latest studies of Lipodystrophy acquired.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
22,879 people reported to have side effects when taking Kaletra.
Among them, 501 people (2.19%) have Lipodystrophy acquired.
Among these 501 people:
How long have people been on Kaletra when they have Lipodystrophy acquired? *
What is the gender of people who have Lipodystrophy acquired when taking Kaletra? *
What is the age of people who have Lipodystrophy acquired when taking Kaletra? *
What are other drugs people take besides Kaletra? *
What are other side effects people have besides Lipodystrophy acquired? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Kaletra and have Lipodystrophy acquired?
- Check whether Lipodystrophy acquired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Kaletra:
- Kaletra (23,070 reports)
Lipodystrophy acquired treatments and more:
- Lipodystrophy acquired (5,451 reports)
How severe was Lipodystrophy acquired and when was it recovered:
Expand to all the drugs that have ingredients of lopinavir; ritonavir:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Kaletra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Lipodystrophy acquired:
- Lipodystrophy acquired (174 drugs)
Browse all the conditions that are associated with Lipodystrophy acquired:
- Lipodystrophy acquired (238 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lopinavir; ritonavir (the active ingredients of Kaletra) and Kaletra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Profen cause Subcutaneous Emphysema? - 11 seconds ago
- Insulin and Presyncope for Men aged 60+ - 12 seconds ago
- Pain and Haemolysis - 15 seconds ago
- Atrioventricular Block Complete and drugs of ingredients of zoledronic acid - 27 seconds ago
- High Blood Pressure and Prostate Cancer Metastatic - 28 seconds ago
- Renvela and Ondansetron drug interactions for men aged 50-59 - 35 seconds ago
- Pain and Product Solubility Abnormal - 51 seconds ago
- Dizziness Aggravated in Folic Acid, how severe and when it was recovered? - 57 seconds ago
- Gastritis Haemorrhagic and drugs of ingredients of methotrexate sodium - a minute ago
- Osteoporosis and Urine Abnormality - a minute ago